Therapeutic options for the treatment of cancer-associated thrombosis

Semin Oncol Nurs. 2005 Nov;21(4 Suppl 1):21-40. doi: 10.1016/j.soncn.2005.10.001.

Abstract

Objective: To provide oncology nurses with an understanding of therapeutic options for cancer-associated thrombosis, strategies to prevent recurrence, and practical issues in patient management.

Data sources: Primary and tertiary literature and the author's clinical experience.

Conclusion: Oncology nurses monitor patients throughout the care continuum for signs and symptoms indicating vascular thromboembolism and need to know the steps to take to expedite an accurate diagnosis and ensure prompt treatment.

Implications for nursing practice: Oncology nurses must keep informed about the evolving evidence that leads to practice changes. They should be able to teach patients about therapeutic options and their potential for improving outcomes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anticoagulants / adverse effects
  • Hemorrhage / chemically induced
  • Humans
  • Neoplasms / complications*
  • Oncology Nursing / methods*
  • Risk Factors
  • Vena Cava Filters
  • Venous Thrombosis* / diagnosis
  • Venous Thrombosis* / etiology
  • Venous Thrombosis* / therapy
  • Warfarin / adverse effects

Substances

  • Anticoagulants
  • Warfarin